Robert Nicholas Severinac, MD | |
10020 Dupont Circle Ct, Suite 100, Fort Wayne, IN 46825-1620 | |
(260) 489-0099 | |
(260) 489-0066 |
Full Name | Robert Nicholas Severinac |
---|---|
Gender | Male |
Speciality | |
Experience | Years |
Location | 10020 Dupont Circle Ct, Fort Wayne, Indiana |
Accepts Medicare Assignments | May be. He may accept the Medicare-approved amount; you may be billed for more than the Medicare deductible and coinsurance. |
Identifier | Type | State | Issuer |
---|---|---|---|
1033120969 | NPI | - | NPPES |
Taxonomy | Type | License (State) | Status |
---|---|---|---|
208200000X | Plastic Surgery | 01043388A (Indiana) | Primary |
Mailing Address | Practice Location Address |
---|---|
Robert Nicholas Severinac, MD 10020 Dupont Circle Ct, Suite 100, Fort Wayne, IN 46825-1620 Ph: (260) 489-0099 | Robert Nicholas Severinac, MD 10020 Dupont Circle Ct, Suite 100, Fort Wayne, IN 46825-1620 Ph: (260) 489-0099 |
News Archive
A combination of the myxoma virus and the immune suppressant rapamycin can kill glioblastoma multiforme, the most common and deadliest malignant brain tumor, according to Moffitt Cancer Center research.
Arrowhead Research Corporation today announced that its portfolio company, Nanotope, Inc., has entered into an agreement with Smith & Nephew, Inc., a member of the Smith & Nephew plc group to develop a cartilage regeneration product for human healthcare markets using a subset of its proprietary regenerative medicine technology.
Optimer Pharmaceuticals, Inc. today announced that the Committee for Medicinal Products for Human Use (CHMP) of the European Medicines Agency (EMA) has adopted a positive opinion for DIFICLIR (fidaxomicin) tablets for the treatment of adults suffering with a Clostridium difficile infection (CDI), also known as C. difficile-associated diarrhea.
PharmaNet Development Group, Inc., a leading provider of clinical development services to pharmaceutical, biotechnology, generic drug and medical device companies, is pleased to announce that it is launching two technology platforms – Initiator™ and PKS™ - that will provide dramatic improvements in clinical study timelines by accelerating data acquisition and the processing of final client reports in its Phase I clinics. By providing clients with real time data faster, sponsors can make informed decisions about their products earlier in the process.
Soligenix, Inc., a late-stage biotechnology company, announced today that the European Patent Office granted patent EP 1392321 "Method of Treating Inflammatory Disorders of the Gastrointestinal Tract using Topically Active Corticosteroids." The new patent's main claims cover the use of topically active corticosteroids in orally administered dosage forms that act concurrently in the upper and lower gastrointestinal tract.
› Verified 3 days ago
Dr. Reid Robert Pflueger, D.O. Plastic Surgery Medicare: Accepting Medicare Assignments Practice Location: 7920 W Jefferson Blvd Ste 200, Fort Wayne, IN 46804 Phone: 260-490-7111 | |
Guy G Crevecoeur, MD Plastic Surgery Medicare: Accepting Medicare Assignments Practice Location: 11141 Parkview Plaza Dr Ste 300, Fort Wayne, IN 46845 Phone: 260-490-7111 Fax: 260-490-2286 | |
Kevin L Berning, MD Plastic Surgery Medicare: Accepting Medicare Assignments Practice Location: 11141 Parkview Plaza Dr Ste 300, Fort Wayne, IN 46845 Phone: 260-490-7111 Fax: 260-490-2286 | |
Geoffrey M Randolph, MD Plastic Surgery Medicare: Not Enrolled in Medicare Practice Location: 11141 Parkview Plaza Dr Ste 300, Fort Wayne, IN 46845 Phone: 260-490-7111 Fax: 260-490-9301 | |
Albert M Morrison, MD Plastic Surgery Medicare: Accepting Medicare Assignments Practice Location: 11141 Parkview Plaza Dr Ste 300, Fort Wayne, IN 46845 Phone: 260-425-6960 Fax: 260-425-6965 | |
James R. Miller, M.D. Plastic Surgery Medicare: Accepting Medicare Assignments Practice Location: 11141 Parkview Plaza Dr, Suite 305, Fort Wayne, IN 46845 Phone: 260-266-8900 Fax: 260-266-8935 |